Press Releases Ypsomed Group

Burgdorf - OptiClik, developed and manufactured by Ypsomed, is the first "semi-disposable" insulin pen-system now launched by Sanofi-Aventis for its long-acting insulin Lantus in the US market. The market launch of OptiClik is a major milestone within Ypsomed's growth strategy.

Go back